BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 18587015)

  • 1. Epigenetic dysregulation of the DAP kinase/p14/HDM2/p53/Apaf-1 apoptosis pathway in acute leukaemias.
    Chim CS; Chan WW; Kwong YL
    J Clin Pathol; 2008 Jul; 61(7):844-7. PubMed ID: 18587015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic dysregulation of the death-associated protein kinase/p14/HDM2/p53/Apaf-1 apoptosis pathway in multiple myeloma.
    Chim CS; Liang R; Fung TK; Choi CL; Kwong YL
    J Clin Pathol; 2007 Jun; 60(6):664-9. PubMed ID: 17557868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent DAP kinase but not p14 or Apaf-1 hypermethylation in B-cell chronic lymphocytic leukemia.
    Chim CS; Fung TK; Wong KF; Lau JS; Liang R
    J Hum Genet; 2006; 51(9):832-838. PubMed ID: 16897188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic inactivation of DAPK1, p14ARF, mir-34a and -34b/c in acute promyelocytic leukaemia.
    Ng HY; Wan TS; So CC; Chim CS
    J Clin Pathol; 2014 Jul; 67(7):626-31. PubMed ID: 24811488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA hypermethylation of cell cycle (p15 and p16) and apoptotic (p14, p53, DAPK and TMS1) genes in peripheral blood of leukemia patients.
    Bodoor K; Haddad Y; Alkhateeb A; Al-Abbadi A; Dowairi M; Magableh A; Bsoul N; Ghabkari A
    Asian Pac J Cancer Prev; 2014; 15(1):75-84. PubMed ID: 24528084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleolar p14(ARF) overexpression in Reed-Sternberg cells in Hodgkin's lymphoma: absence of p14(ARF)/Hdm2 complexes is associated with expression of alternatively spliced Hdm2 transcripts.
    García JF; Villuendas R; Sánchez-Beato M; Sánchez-Aguilera A; Sánchez L; Prieto I; Piris MA
    Am J Pathol; 2002 Feb; 160(2):569-78. PubMed ID: 11839577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic inactivation of the CIP/KIP cell-cycle control pathway in acute leukemias.
    Chim CS; Wong AS; Kwong YL
    Am J Hematol; 2005 Dec; 80(4):282-7. PubMed ID: 16315255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias.
    Chim CS; Wong AS; Kwong YL
    Ann Hematol; 2003 Dec; 82(12):738-42. PubMed ID: 14513284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 apoptotic pathway molecules are frequently and simultaneously altered in nonsmall cell lung carcinoma.
    Mori S; Ito G; Usami N; Yoshioka H; Ueda Y; Kodama Y; Takahashi M; Fong KM; Shimokata K; Sekido Y
    Cancer; 2004 Apr; 100(8):1673-82. PubMed ID: 15073856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of DNA methylation in the suppression of Apaf-1 protein in human leukaemia.
    Fu WN; Bertoni F; Kelsey SM; McElwaine SM; Cotter FE; Newland AC; Jia L
    Oncogene; 2003 Jan; 22(3):451-5. PubMed ID: 12545166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-apoptotic response to therapeutic DNA damage involves protein modulation of Mcl-1, Hdm2 and Flt3 in acute myeloid leukemia cells.
    Wergeland L; Sjøholt G; Haaland I; Hovland R; Bruserud Ø; Gjertsen BT
    Mol Cancer; 2007 May; 6():33. PubMed ID: 17498302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased frequency of aberrations in the p53/MDM2/p14(ARF) pathway in neuroblastoma cell lines established at relapse.
    Carr J; Bell E; Pearson AD; Kees UR; Beris H; Lunec J; Tweddle DA
    Cancer Res; 2006 Feb; 66(4):2138-45. PubMed ID: 16489014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter hypermethylation profile of kidney cancer with new proapoptotic p53 target genes and clinical implications.
    Christoph F; Weikert S; Kempkensteffen C; Krause H; Schostak M; Köllermann J; Miller K; Schrader M
    Clin Cancer Res; 2006 Sep; 12(17):5040-6. PubMed ID: 16951219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.
    Watanabe T; Katayama Y; Yoshino A; Komine C; Yokoyama T
    Clin Cancer Res; 2003 Oct; 9(13):4884-90. PubMed ID: 14581362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of p53 tumor suppressor pathway genes in chronic lymphocytic leukemia.
    Isin M; Yenerel M; Aktan M; Buyru N; Dalay N
    DNA Cell Biol; 2012 May; 31(5):777-82. PubMed ID: 22047081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 Pathway dysfunction in primary childhood ependymomas.
    Gaspar N; Grill J; Geoerger B; Lellouch-Tubiana A; Michalowski MB; Vassal G
    Pediatr Blood Cancer; 2006 May; 46(5):604-13. PubMed ID: 16086408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic dysregulation of the Jak/STAT pathway by frequent aberrant methylation of SHP1 but not SOCS1 in acute leukaemias.
    Chim CS; Wong AS; Kwong YL
    Ann Hematol; 2004 Aug; 83(8):527-32. PubMed ID: 14762685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies.
    Katzenellenbogen RA; Baylin SB; Herman JG
    Blood; 1999 Jun; 93(12):4347-53. PubMed ID: 10361133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation silencing of the Apaf-1 gene in acute leukemia.
    Furukawa Y; Sutheesophon K; Wada T; Nishimura M; Saito Y; Ishii H; Furukawa Y
    Mol Cancer Res; 2005 Jun; 3(6):325-34. PubMed ID: 15972851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.